ZA927646B - Amidinoaphthyl furancarboxylate derivatives and acid addition salts thereof. - Google Patents
Amidinoaphthyl furancarboxylate derivatives and acid addition salts thereof.Info
- Publication number
- ZA927646B ZA927646B ZA927646A ZA927646A ZA927646B ZA 927646 B ZA927646 B ZA 927646B ZA 927646 A ZA927646 A ZA 927646A ZA 927646 A ZA927646 A ZA 927646A ZA 927646 B ZA927646 B ZA 927646B
- Authority
- ZA
- South Africa
- Prior art keywords
- group
- alkyl
- substituted
- alkenyl
- acid addition
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/34—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Urology & Nephrology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Immunology (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Furan Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Plural Heterocyclic Compounds (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP4023848A JPH05213927A (ja) | 1992-02-10 | 1992-02-10 | 新規フランカルボン酸アミジノナフチルエステル誘導体およびその酸付加塩 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA927646B true ZA927646B (en) | 1993-04-13 |
Family
ID=12121832
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA927646A ZA927646B (en) | 1992-02-10 | 1992-10-05 | Amidinoaphthyl furancarboxylate derivatives and acid addition salts thereof. |
Country Status (16)
| Country | Link |
|---|---|
| EP (1) | EP0556024B1 (xx) |
| JP (1) | JPH05213927A (xx) |
| KR (1) | KR100229254B1 (xx) |
| AT (1) | ATE125806T1 (xx) |
| AU (1) | AU652076B2 (xx) |
| CA (1) | CA2079267A1 (xx) |
| DE (1) | DE69300307T2 (xx) |
| DK (1) | DK0556024T3 (xx) |
| FI (1) | FI925311A (xx) |
| HU (1) | HUT63841A (xx) |
| MX (1) | MX9205914A (xx) |
| NO (1) | NO300633B1 (xx) |
| PL (1) | PL174421B1 (xx) |
| RU (1) | RU2096410C1 (xx) |
| TW (1) | TW232687B (xx) |
| ZA (1) | ZA927646B (xx) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU1208999A (en) * | 1997-11-10 | 1999-05-31 | Array Biopharma, Inc. | Compounds which inhibit tryptase activity |
| US6362216B1 (en) | 1998-10-27 | 2002-03-26 | Array Biopharma Inc. | Compounds which inhibit tryptase activity |
| JP3395061B2 (ja) | 2000-02-21 | 2003-04-07 | 学校法人金沢工業大学 | 図書館の蔵書自動出納システムと図書館の蔵書出納ロボットならびに図書館の蔵書出納ロボットのハンド機構 |
| GB0507577D0 (en) | 2005-04-14 | 2005-05-18 | Novartis Ag | Organic compounds |
| JP5959116B2 (ja) * | 2011-06-07 | 2016-08-02 | Ｅａファーマ株式会社 | ヘテロ環カルボン酸エステル誘導体 |
| US9024044B2 (en) * | 2012-06-14 | 2015-05-05 | Ajinomoto Co., Inc. | Heteroarylcarboxylic acid ester derivative |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS59139357A (ja) * | 1983-01-28 | 1984-08-10 | Torii Yakuhin Kk | アミジン誘導体 |
| US4563527A (en) * | 1984-07-19 | 1986-01-07 | Torii & Co., Ltd. | Amidine compounds |
-
1992
- 1992-02-10 JP JP4023848A patent/JPH05213927A/ja active Pending
- 1992-09-25 TW TW081107606A patent/TW232687B/zh active
- 1992-09-28 CA CA002079267A patent/CA2079267A1/en not_active Abandoned
- 1992-09-28 AU AU25378/92A patent/AU652076B2/en not_active Ceased
- 1992-10-05 ZA ZA927646A patent/ZA927646B/xx unknown
- 1992-10-15 MX MX9205914A patent/MX9205914A/es not_active IP Right Cessation
- 1992-11-12 KR KR1019920021250A patent/KR100229254B1/ko not_active IP Right Cessation
- 1992-11-23 FI FI925311A patent/FI925311A/fi unknown
- 1992-12-09 RU RU9292004533A patent/RU2096410C1/ru active
- 1992-12-09 NO NO924758A patent/NO300633B1/no not_active IP Right Cessation
- 1992-12-10 HU HU9203908A patent/HUT63841A/hu unknown
-
1993
- 1993-02-02 PL PL93297964A patent/PL174421B1/pl unknown
- 1993-02-09 EP EP93300938A patent/EP0556024B1/en not_active Expired - Lifetime
- 1993-02-09 AT AT93300938T patent/ATE125806T1/de not_active IP Right Cessation
- 1993-02-09 DE DE69300307T patent/DE69300307T2/de not_active Expired - Fee Related
- 1993-02-09 DK DK93300938.3T patent/DK0556024T3/da active
Also Published As
| Publication number | Publication date |
|---|---|
| RU2096410C1 (ru) | 1997-11-20 |
| NO924758L (no) | 1993-08-11 |
| EP0556024A1 (en) | 1993-08-18 |
| PL297964A1 (en) | 1993-10-18 |
| KR100229254B1 (ko) | 1999-11-01 |
| CA2079267A1 (en) | 1993-08-11 |
| NO924758D0 (no) | 1992-12-09 |
| AU2537892A (en) | 1993-08-12 |
| ATE125806T1 (de) | 1995-08-15 |
| HUT63841A (en) | 1993-10-28 |
| TW232687B (xx) | 1994-10-21 |
| KR930017884A (ko) | 1993-09-20 |
| AU652076B2 (en) | 1994-08-11 |
| NO300633B1 (no) | 1997-06-30 |
| PL174421B1 (pl) | 1998-07-31 |
| DE69300307T2 (de) | 1996-01-25 |
| EP0556024B1 (en) | 1995-08-02 |
| HU9203908D0 (en) | 1993-04-28 |
| JPH05213927A (ja) | 1993-08-24 |
| DE69300307D1 (de) | 1995-09-07 |
| FI925311A (fi) | 1993-08-11 |
| MX9205914A (es) | 1993-09-01 |
| FI925311A0 (fi) | 1992-11-23 |
| DK0556024T3 (da) | 1995-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU680704B2 (en) | Cyclic amide derivatives | |
| FI914187A0 (fi) | Menetelmä valmistaa kaavan /I/ mukaista 1-metyylikarbapeneemijohdosta | |
| FI952059A0 (fi) | Menetelmä taksaanijohdannaisten valmistamiseksi | |
| TW232687B (xx) | ||
| AU645090B2 (en) | Novel N-Benzyl-N-Phenyl and -Phenalkyl-Thioureas | |
| HUT57039A (en) | Process for producing pharmaceutical compositions | |
| CA2078141A1 (en) | Acyl phosphate esters and modification of proteins therewith | |
| NZ234450A (en) | Substituted pyrrolo(2,1-b)thiazole derivatives, intermediates and pharmaceutical compositions |